Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Reneo Pharmaceuticals, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 131K | Oct 4, 2024 | Direct | ||
Reneo Pharmaceuticals, Inc. | Chief Financial Officer | Class A Common Stock | 16.3K | Oct 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OKUR | OnKure Therapeutics, Inc. | Oct 4, 2024 | 4 | $0 | 4 | Oct 8, 2024 | Chief Financial Officer |
OKUR | OnKure Therapeutics, Inc. | Oct 4, 2024 | 0 | $0 | 3 | Oct 8, 2024 | Chief Financial Officer |